We are live on ! Find out more
RNAM

Avidity Biosciences
RNAM

Delisted

RNAM was delisted on the 26th of February, 2026.

Back to rankings

1 hedge funds and large institutions have $236K invested in Avidity Biosciences in 2026 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 335 closing their positions.

New
Increased
Maintained
Reduced
Closed

99.36% less ownership

Funds ownership: 99.37% → 0.01% (-99%)

100% less funds holding

Funds holding: 343 → 1 (-342)

100% less funds holding in top 10

Funds holding in top 10: 33 → 0 (-33)

100% less capital invested

Capital invested by funds: $10.8B → $236K (-$10.8B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 335

Holders
1
Holders Change
-342
Holders Change %
-99.71%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
-33
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
335
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$927M
2
RCM
RA Capital Management
Massachusetts
-$623M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$501M
4
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$436M
5
PCM
Pentwater Capital Management
Florida
-$435M
Name Holding Trade Value Shares
Change 		Change in
Stake
AF
301
Advisornet Financial
Minnesota
– -$14.2K -197 Closed
VCM
302
Versant Capital Management
Arizona
– -$14K -194 Closed
SL
303
Salomon & Ludwin
Virginia
– -$13.9K -193 Closed
AAP
304
Arax Advisory Partners
Colorado
– -$13.5K -187 Closed
RIL
305
Rothschild Investment LLC
Illinois
– -$13.5K -187 Closed
CAL
306
Capital Analysts LLC
Pennsylvania
– -$10K -143 Closed
EWA
307
EverSource Wealth Advisors
Alabama
– -$8.73K -121 Closed
PWMG
308
Private Wealth Management Group
New Jersey
– -$7.21K -100 Closed
PFBT
309
Parkside Financial Bank & Trust
Missouri
– -$4.33K -60 Closed
CA
310
Centerpoint Advisors
Massachusetts
– -$4K -50 Closed
MAM
311
Meeder Asset Management
Ohio
– -$3.46K -48 Closed
RFP
312
Root Financial Partners
California
– -$3.03K -42 Closed
BIA
313
Bell Investment Advisors
California
– -$2.89K -40 Closed
BFS
314
Bare Financial Services
Pennsylvania
– -$2.67K -37 Closed
TFA
315
Transamerica Financial Advisors
Florida
– -$2.38K -33 Closed
SS
316
SBI Securities
Japan
– -$1.23K -17 Closed
Northwestern Mutual Wealth Management
317
Northwestern Mutual Wealth Management
Wisconsin
– -$1.08K -15 Closed
TWD
318
True Wealth Design
Ohio
– -$1.08K -15 Closed
MAM
319
Marquette Asset Management
Minnesota
– -$1.01K -14 Closed
CFM
320
Cornerstone Financial Management
Massachusetts
– -$793 -11 Closed
TCM
321
TD Capital Management
Tennessee
– -$721 -10 Closed
TC
322
Truvestments Capital
Florida
– -$721 -10 Closed
ZBNA
323
Zions Bancorporation, National Association
Utah
– -$721 -10 Closed
RWM
324
Rialto Wealth Management
New York
– -$578 -8 Closed
FFO
325
Fortitude Family Office
Arizona
– -$433 -6 Closed
10 11 12
13
14

RNAM Hedge Fund Activity: Q1 2026 in Review

1 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Avidity Biosciences (RNAM) for Q1 2026, worth a combined $236K — down 100% from $10.8B a quarter earlier.

Sellers outnumbered buyers: 335 funds closed out of RNAM and 0 opened new positions — a net loss of 335 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $927M sold.

  • 1 institutional investor held Avidity Biosciences (RNAM) as of Q1 2026, down from 343 in Q4 2025.
  • Funds reported $236K of Avidity Biosciences stock for Q1 2026, down 100% quarter-over-quarter.
  • 0 funds opened new Avidity Biosciences positions in Q1 2026 and 335 closed out, a net change of -335 holders.
  • The largest Avidity Biosciences seller in Q1 2026 was BlackRock, an estimated $927M sold.

Based on aggregated 13F filings for Q1 2026.